These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26570)

  • 1. Formation of complexes between microsomal cytochrome P-450-Fe(II) and nitrosoarenes obtained by oxidation of arylhydroxylamines or reduction of nitroarenes in situ.
    Mansuy D; Beaune P; Cresteil T; Bacot C; Chottard JC; Gans P
    Eur J Biochem; 1978 May; 86(2):573-9. PubMed ID: 26570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrosoalkanes as Fe(II) ligands in the 455-nm-absorbing cytochrome P-450 complexes formed from nitroalkanes in reducing conditions.
    Mansuy D; Gans P; Chottard JC; Bartoli JF
    Eur J Biochem; 1977 Jun; 76(2):607-15. PubMed ID: 891529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of cytochrome P-450 in the reduction of nitro compounds by rat liver microsomes.
    Harada N; Omura T
    J Biochem; 1980 May; 87(5):1539-54. PubMed ID: 7390998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of benzyl halides by liver microsomes. Formation of 478 NM-absorbing sigma-alkyl-ferric cytochrome P-450 complexes.
    Mansuy D; Fontecave M
    Biochem Pharmacol; 1983 Jun; 32(12):1871-9. PubMed ID: 6882464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct formation of complexes between cytochrome P-450 and nitrosoarenes.
    Fukuto JM; Brady JF; Burstyn JN; VanAtta RB; Valentine JS; Cho AK
    Biochemistry; 1986 May; 25(9):2714-9. PubMed ID: 3013312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosoalkanes as Fe(II) ligands in the hemoglobin and myoglobin complexes formed from nitroalkanes in reducing conditions.
    Mansuy D; Chottard JC; Chottard G
    Eur J Biochem; 1977 Jun; 76(2):617-23. PubMed ID: 891530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction of monosubstituted hydrazines and diazenes with rat-liver cytochrome P450. Formation of ferrous-diazene and ferric sigma-alkyl complexes.
    Battioni P; Mahy JP; Delaforge M; Mansuy D
    Eur J Biochem; 1983 Aug; 134(2):241-8. PubMed ID: 6873062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of an inactive cytochrome P-450Fe(II)-metabolite complex after administration of amiodarone in rats, mice and hamsters.
    Larrey D; Tinel M; Letteron P; Geneve J; Descatoire V; Pessayre D
    Biochem Pharmacol; 1986 Jul; 35(13):2213-20. PubMed ID: 3729976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of prostaglandin synthase-iron-nitrosoalkane inhibitory complexes upon in situ oxidation of N-substituted hydroxylamines.
    Mahy JP; Mansuy D
    Biochemistry; 1991 Apr; 30(17):4165-72. PubMed ID: 1902377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of nitric oxide synthase-iron(II) nitrosoalkane complexes: severe restriction of access to the iron(II) site in the presence of tetrahydrobiopterin.
    Renodon A; Boucher JL; Wu C; Gachhui R; Sari MA; Mansuy D; Stuehr D
    Biochemistry; 1998 May; 37(18):6367-74. PubMed ID: 9572852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of nitrosobenzene, phenylhydroxylamine, and aniline in the isolated perfused rat liver.
    Eyer P; Kampffmeyer H; Maister H; Rösch-Oehme E
    Xenobiotica; 1980; 10(7-8):499-516. PubMed ID: 6893777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation and disposition of N-hydroxylated metabolites of aniline and nitrobenzene by isolated rat hepatocytes.
    Blaauboer BJ; Van Holsteijn CW
    Xenobiotica; 1983 May; 13(5):295-302. PubMed ID: 6636826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of aromatic nitro compounds with reduced hepatic microsomal cytochrome P-450.
    Sternson LA; Gammans RE
    Drug Metab Dispos; 1975; 3(4):266-74. PubMed ID: 240656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions of prostaglandin H synthase with monosubstituted hydrazines and diazenes. Formation of iron(II)-diazene and iron(III)-sigma-alkyl or iron(III)-sigma-aryl complexes.
    Mahy JP; Gaspard S; Delaforge M; Mansuy D
    Eur J Biochem; 1994 Dec; 226(2):445-57. PubMed ID: 8001562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nature of the "455 nm absorbing complex" formed during the cytochrome P450 dependent oxidative metabolism of amphetamine.
    Mansuy D; Beaune P; Chottard JC; Bartoli JF; Gans P
    Biochem Pharmacol; 1976 Mar; 25(5):609-12. PubMed ID: 942497
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytochrome P-455 nm complex formation in the metabolism of phenylalkylamines. IX. A comparative study with enantiomeric 2-nitroso-1-phenylpropane in microsomes and a reconstituted cytochrome P-450 system from rat liver.
    Paulsen-Sörman U; Jönsson KH; Lindeke B
    Chem Biol Interact; 1988; 67(1-2):49-58. PubMed ID: 3168083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aerobic reduction of Fe(III) complexes by hemoglobin and myoglobin.
    Eguchi LA; Saltman P
    J Biol Chem; 1984 Dec; 259(23):14337-8. PubMed ID: 6548749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of nitrobenzene nitroreductase from Pseudomonas pseudoalcaligenes JS45.
    Somerville CC; Nishino SF; Spain JC
    J Bacteriol; 1995 Jul; 177(13):3837-42. PubMed ID: 7601851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron-EDTA stimulated reduction of indicine N-oxide by the hepatic microsomal fraction, isolated hepatocytes, and the intact rat.
    Powis G; Svingen BA; Degraw C
    Biochem Pharmacol; 1982 Feb; 31(3):293-9. PubMed ID: 6280724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH effects on the N-demethylation and formation of the cytochrome P-450 iron II nitrosoalkane complex for erythromycin derivatives.
    Delaforge M; Ladam P; Bouillé G; Benarous JG; Jaouen M; Girault JP
    Chem Biol Interact; 1992 Dec; 85(2-3):215-27. PubMed ID: 1493610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.